HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
NCT06238284 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-02-02
Summary
This study aims to retrospectively analyze the HER2 expression of gynecological malignant tumors in Chongqing by immunohistochemical detection, and explore the correlation between HER2 level, therapy response and prognosis based on patient clinical information.
Conditions
- Cervical Cancer
- Endometrial Cancer
- Ovarian Cancer
- HER2 Expression
Interventions
- OTHER
-
no intervention
Since it is a retrospective study, no intervention is needed.
Sponsors & Collaborators
-
Chongqing University Cancer Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-26
- Primary Completion
- 2024-03-31
- Completion
- 2024-05-31
More Related Trials
-
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
NCT04651920 ·Status: COMPLETED
-
Molecular Mechanism Study of Uterine Sarcoma
NCT05881967 ·Status: RECRUITING
-
Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
NCT02638402 ·Status: UNKNOWN
-
MRI and Metabolomics Biomarkers for Uterine Malignancy
NCT02528864 ·Status: COMPLETED
-
A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
NCT06925113 ·Status: COMPLETED
-
A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
NCT00858078 ·Status: COMPLETED
-
Clinical Specialty Queue For Gestational Trophoblastic Neoplasia
NCT06681259 ·Status: RECRUITING
-
Retrospective Study of Ovarian Cancer Patients With Brain Metastasis
NCT01258881 ·Status: UNKNOWN
-
Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples
NCT02580799 ·Status: COMPLETED
-
Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression
NCT06760923 ·Status: RECRUITING
-
SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours
NCT06329323 ·Status: NOT_YET_RECRUITING
-
Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
NCT06853730 ·Status: COMPLETED
-
Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor
NCT04572594 ·Status: UNKNOWN
-
Ovarian Cancer Identification on CT Using Deep Learning
NCT06851429 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas
NCT03194347 ·Status: COMPLETED
-
Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors
NCT05985941 ·Status: NOT_YET_RECRUITING
-
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
NCT04190667 ·Status: UNKNOWN
-
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
NCT02538562 ·Status: COMPLETED
-
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.
NCT05832593 ·Status: UNKNOWN
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
NCT05693974 ·Status: UNKNOWN
-
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
NCT05513144 ·Status: UNKNOWN
-
Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools
NCT04626440 ·Status: RECRUITING
-
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
NCT01150682 ·Status: UNKNOWN
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)
NCT05693987 ·Status: UNKNOWN
-
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
NCT06341855 ·Status: RECRUITING ·Phase: NA